Cardiovascular outcomes 50 years after antenatal exposure to betamethasone: Follow-up of a randomised double-blind, placebo-controlled trial.
<h4>Background</h4>Antenatal corticosteroids for women at risk of preterm birth reduce neonatal morbidity and mortality, but there is limited evidence regarding their effects on long-term health. This study assessed cardiovascular outcomes at 50 years after antenatal exposure to corticos...
Main Authors: | Anthony G B Walters, Greg D Gamble, Caroline A Crowther, Stuart R Dalziel, Carl L Eagleton, Christopher J D McKinlay, Barry J Milne, Jane E Harding |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-04-01
|
Series: | PLoS Medicine |
Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004378&type=printable |
Similar Items
-
Effects of Antenatal Betamethasone and Dexamethasone in Preterm Neonates
by: Chen-Yu Chen, et al.
Published: (2005-09-01) -
Antenatal Betamethasone Every 12 Hours in Imminent Preterm Labour
by: Natalia Saldaña-García, et al.
Published: (2022-02-01) -
Topical betamethasone and hyaluronidase in the treatment of phimosis in boys: a double-blind, randomized, placebo-controlled trial
by: Fabio J. Nascimento, et al.
Published: (2011-06-01) -
Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE)
by: Thomas Schmitz, et al.
Published: (2019-02-01) -
Effect of Maternal Body Mass Index on the Efficacy of Antenatal Betamethasone Administration in Neonatal Outcomes
by: Masoumeh Mirzamoradi, et al.
Published: (2022-07-01)